We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
+29.26%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$170M
AUM Growth
+$8.04M
Cap. Flow
-$29.1M
Cap. Flow %
-17.06%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
3
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
KALV
KalVista Pharmaceuticals
KALV
+$15.5M
2
TECX
Tectonic Therapeutic
TECX
+$12.3M
3
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$1.28M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALV
1
DELISTED
KalVista Pharmaceuticals
KALV
$52.4M 30.75%
1,831,548
-716,654
-28% -$15.5M
TECX
2
Tectonic Therapeutic
TECX
$717M
$42.6M 24.97%
160,892
-67,110
-29% -$12.3M
DCPH
3
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$28.7M 16.86%
1,238,198
-49,029
-4% -$1.28M
STRO icon
4
Sutro Biopharma
STRO
$353M
$20.8M 12.19%
182,454
– –
ASXC
5
DELISTED
Asensus Surgical, Inc.
ASXC
$15.8M 9.26%
510,141
– –
XFOR icon
6
X4 Pharmaceuticals
XFOR
$419M
$5.42M 3.18%
10,383
– –
OCUL icon
7
Ocular Therapeutix
OCUL
$2.38B
$2.49M 1.46%
628,236
– –
ATXS
8
DELISTED
Astria Therapeutics
ATXS
$2.26M 1.33%
47,628
– –
ETRM
9
DELISTED
EnteroMedics Inc.
ETRM
– –
-1,072
Closed –

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q1 2019 Portfolio in Review

As of Q1 2019, SV Health Investors held 9 positions worth $170M, up 5% from $162M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors withdrew a net $29.1M in Q1 2019, closing 1 position and reducing 3 holdings. Its most notable exit was EnteroMedics Inc., an estimated $0 position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • SV Health Investors's biggest Q1 2019 reduction was KalVista Pharmaceuticals, cutting an estimated $15.5M.
  • SV Health Investors fully exited EnteroMedics Inc. in Q1 2019, selling an estimated $0.
  • SV Health Investors's ten largest holdings make up 100% of its $170M portfolio in Q1 2019.
  • SV Health Investors opened 0 new positions and closed 1 in Q1 2019.
  • SV Health Investors's portfolio value rose 5% quarter-over-quarter to $170M.

Based on SV Health Investors's 13F filing for Q1 2019, filed 15 May 2019.